At Novartis, we are an innovative medicines company driven by our purpose: to reimagine medicine and improve and extend people's lives. Every day, we strive to empower individuals, healthcare professionals, and societies in the face of serious diseases.
By leveraging technological leadership in R&D and novel access approaches, we deliver high-value medicines designed to alleviate society’s greatest disease burdens. Our goal is clear—to transform the healthcare landscape through early interventions, pioneering treatments, and innovative partnerships. We specifically target cardiovascular disease (CVD)—the world’s biggest killer—and rare and progressive kidney diseases, aiming to prevent avoidable mortality and ease the burden on individuals by extending dialysis-free life.
In this new era, our commitment remains unwavering. Together, let’s reimagine medicine to improve and extend people’s lives.
27 June -
28 June 2025
Europe/ParisMasterclass in AI and Cardiovascular HealthAccess event page https://esc365.escardio.org/event/1930
true
2025-06-27T11:30:002025-06-28T19:00:00
Register to Access
Masterclass in AI and Cardiovascular Health
8 July 2025
18:00
CET
Europe/ParisAdvanced deep learning in cardiologyAccess event page https://esc365.escardio.org/event/20212025-07-08T18:00:002025-07-08T19:00:00
Register to Access
Advanced deep learning in cardiology
5 September 2025
18:00
CET
Europe/ParisBuilding clinical-decision support tools empowered by AIAccess event page https://esc365.escardio.org/event/20222025-09-05T18:00:002025-09-05T19:00:00
Register to Access
Building clinical-decision support tools empowered by AI
15 October 2025
18:00
CET
Europe/ParisUnlocking insights from cardiology data with NLPAccess event page https://esc365.escardio.org/event/20002025-10-15T18:00:002025-10-15T19:00:00